HIFIBIO
Description:
- High throughput, high-precision quantitative screening for the discovery of new drugs.
- HiFiBiO is a pioneering company offering a complete innovative technology that generates unparalleled opportunities for the discovery of new therapeutic antibodies against complex targets.
- HiFiBiO has engaged in multiple collaborations with the world's leading pharmaceutical companies to discover new therapeutic antibodies.
At the origin of the project
- Andrew GRIFFITH
ISIS (Institute of Supramolecular Science and Engineering)
CNRS - University of Strasbourg